Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus versus cyclophosphamide for severe lupus nephritis
ChiCTR-TNRC-10000960Phase 4Completed
- Sponsor
- Zhejiang University School of Medicine
- Start
- Mar 2003
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tacrolimus, cyclophosphamide, azathioprine and prednisone in lupus nephritis (LN) (2 arms), sponsored by Zhejiang University School of Medicine. Primary endpoints: SLE Disease Activity Index, creatinine clearance and 6 more. Started Mar 2003; status: completed.
02
Drugs
tacrolimuscyclophosphamideazathioprineprednisone
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on ChiCTR-TNRC-10000960.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TNRC-10000960.